Israel Biotech Fund

Founded -
Founders David Sidransky Yuval Cabilly

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$24M
Portfolio companies 7
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Exits 2
Key employees 3

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Biopharma

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Life Science
Pharmaceutical
$28M13 May 2021 Jerusalem, Jerusalem District, Israel

BioSight

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$27M02 Dec 2020 Israel, North District

BioSight

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$19M11 Mar 2020 Israel, North District

Ayala Pharmaceuticals

Biotechnology
Pharmaceutical
$30M28 May 2019 Israel, Center District

Biond Biologics

Biotechnology
Health Care
Pharmaceutical
$17M08 Jan 2019 Israel, North District

Ayala Pharmaceuticals

Biotechnology
Pharmaceutical
$17M10 Apr 2018 Israel, Center District

Gamida Cell

Biotechnology
Health Care
Medical Device
Therapeutics
$40M19 Jun 2017 Israel, Jerusalem District

Biopharma
Biotechnology
Pharmaceutical
$30M27 Feb 2017 Rishon Lezion, Center District, Israel

Vidac Pharma

Biopharma
Biotechnology
Clinical Trials
Health Care
Pharmaceutical
$9M29 Jun 2016 Israel, Jerusalem District
News
Vensica Therapeutics Closes $16 Million Investment Round

– Vensica closed an investment round of $16m.
– The round was led by Israel Biotech Fund (“IBF”), a venture fund investing in Israeli and Israeli-related biotechnology and pharmaceutical companies.
– Other investors in the round include Laborie, a global urology device company, Lew Pell, an experienced medical device investor, Agriline, a trust of which Vincent Tchenguiz is a discretionary beneficiary, and The Trendlines Group, an investor in innovation-based medical and agricultural technologies.
– Funds raised will support the company’s phase II multicenter clinical trials in Europe and the USA.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Israel Biotech Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: